Phase I study of ixabepilone in combination with capecitabine in Japanese patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

被引：1
|
作者：
Watanabe, J.
Horiguchi, J.
Masuda, N.
Aogi, K.
Sato, R.
Tokudome, T.
Peck, R. A.
机构：
[1] Shizuoka Canc Ctr, Shizuoka, Japan
[2] Gunma Univ, Sch Med, Maebashi, Gunma 371, Japan
[3] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
[4] Natl Hosp Org Shikoku Canc Ctr, Eihme, Japan
[5] Bristol Myers Squibb KK, Tokyo, Japan
[6] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13095
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
    Ji Soo Park
    Hei-Cheul Jeung
    Sun Young Rha
    Joong Bae Ahn
    Beodeul Kang
    Hong Jae Chon
    Min Hee Hong
    Seungtaek Lim
    Woo Ick Yang
    Chung Mo Nam
    Hyun Cheol Chung
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 799 - 808
  • [22] A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen
    Lida Mina
    Ian Krop
    Robin T. Zon
    Steven J. Isakoff
    Charles J. Schneider
    Menggang Yu
    Cindy Johnson
    LaTrice G. Vaughn
    Yanping Wang
    Maria Hristova-Kazmierski
    Oluwatoyin O. Shonukan
    George W. Sledge
    Kathy D. Miller
    Investigational New Drugs, 2009, 27 : 565 - 570
  • [23] A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen
    Mina, Lida
    Krop, Ian
    Zon, Robin T.
    Isakoff, Steven J.
    Schneider, Charles J.
    Yu, Menggang
    Johnson, Cindy
    Vaughn, LaTrice G.
    Wang, Yanping
    Hristova-Kazmierski, Maria
    Shonukan, Oluwatoyin O.
    Sledge, George W.
    Miller, Kathy D.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (06) : 565 - 570
  • [24] A Phase I Study of Ixabepilone in Combination With Epirubicin in Patients With Metastatic Breast Cancer
    Roche, Henri
    De Benedictis, Elena
    Cottura, Ewa
    Govi, Silvia
    Dalenc, Florence
    Locatelli, Alberta
    Deslandres, Marion
    Zambetti, Milvia
    Gladieff, Laurence
    Messina, Marianne
    Gianni, Luca
    CLINICAL BREAST CANCER, 2012, 12 (03) : 167 - 174
  • [25] Efficacy of the CMFVP Regimen in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane
    Grenader, Tal
    ONKOLOGIE, 2012, 35 (1-2): : 24 - 26
  • [26] Phase II study of irinotecan plus capecitabine in patients with anthracycline and taxane pretreated metastatic breast cancer
    Lee, K. S.
    Ro, J.
    Park, I. H.
    Kim, E. A.
    Nam, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Efficacy and Safety of Capecitabine Alone or in Combination in Advanced Metastatic Breast Cancer Patients Previously Treated with Anthracycline and Taxane: A Systematic Review and Meta-Analysis
    Alsaloumi, Louai
    Shawagfeh, Shaima
    Abdi, Abdikarim
    Basgut, Bilgen
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12) : 694 - 702
  • [28] Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Vahdat, Linda T.
    Vrdoljak, Eduard
    Gomez, Henry
    Li, Rubi Khaw
    Bosserman, Linda
    Sparano, Joseph A.
    Baselga, Jose
    Mukhopadhyay, Pralay
    Valero, Vicente
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (04) : 346 - 352
  • [29] Cost Effectiveness of Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
    Reed, Shelby D.
    Li, Yanhong
    Anstrom, Kevin J.
    Schulman, Kevin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2185 - 2191
  • [30] BAY 43-9006 as single oral agent in patients with metastatic breast cancer previously exposed to anthracycline and/or taxane.
    Moreno-Aspitia, A.
    Hillman, D. W.
    Wiesenfeld, M.
    Hobday, T. J.
    Rowland, K. M.
    Northfelt, D. W.
    Tenner, K. S.
    Palmieri, F. M.
    Perez, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 22S - 22S
12345